本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

1.49
-0.1100-6.87%
盘后1.520.0300+2.01%19:58 EDT
成交量:307.97万
成交额:468.10万
市值:1.06亿
市盈率:-2.78
高:1.63
开:1.63
低:1.48
收:1.60
52周最高:2.01
52周最低:0.2425
股本:7,110.95万
流通股本:5,952.45万
量比:2.60
换手率:5.17%
股息:- -
股息率:- -
每股收益(TTM):-0.5359
每股收益(LYR):-0.3663
净资产收益率:-52.77%
总资产收益率:-26.71%
市净率:1.90
市盈率(LYR):-4.07

数据加载中...

2023/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/07/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

重要事件披露

8-K - Current report
2023/05/01

重要事件披露

8-K - Current report
2023/04/27

重要事件披露

8-K - Current report
2023/03/13

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals